1Altman RD,Hochberg MC,Moskowitz KW,et al.Recommendations for the Medical management of osteoarthritis of the hip and knee.2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines[].Arthritis and Rheumatism.2000 被引量：1
2Ahmad SR,Kortepeter C,Brinker A,et al.Renal failure associated with the use of celecoxib and rofecoxib[].Drug Safety.2002 被引量：1
3Peloso PM.Opioid therapy for osteoarthritis of the hip and knee: use it for lose it[].The Journal of Rheumatology.2001 被引量：1
4Reginster JY,Deroisy R,Rovati LC,et al.Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebocontrolled clinical trial[].The Lancet.2001 被引量：1
5Pavelka K,Catterovd J,Olejarovd M,et al.Glucosamine sulfate use and delay of progression of knee osteoarthritis[].Archives of Internal Medicine.2002 被引量：1
6Mendes AF,Caramona MM,Carvalho AP,et al.Diacerhein and rhein prevent interleukin-1 beta induced nuclear factor-kappa B activation by inhibiting the degradation of inhibitor kappa B-alpha[].Pharmacology and Toxicology.2002 被引量：1
7Pelletier JP,Yaron M,Haraoui B,et al.Efficacy and safety of diacerein in osteoarthritis of the knee: a double- blind, placebo- controlled trial.The Diacerein Study Group[].Arthritis and Rheumatism.2000 被引量：1
